Who backs BRL Medicine?
14 investors| Investor | Type |
|---|---|
| Oriental Fortune Capital | Venture capital |
| Zizhu Xiaomiao PE | Venture capital |
| Gopher Asset Management | Asset manager |
| Ancheng Capital | Other |
| China Resources Capital Management | Other |
| Betta Pharmaceutical Biotechnology Fund | — |
| CSPC Pharmaceutical Group Company | — |
| Hangzhou Betta Investment | — |
| HuaE Finance Management | — |
| Shanghai Free Trade Zone Equity Fund | — |
| + 4 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
BRL Medicine investors
14 investors are on record for BRL Medicine, including Oriental Fortune Capital, Zizhu Xiaomiao PE, Gopher Asset Management and Ancheng Capital.
Free account
More of BRL Medicine with a free account
- ·The complete investor list: 14 names
- ·Watch BRL Medicine: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 14 firms already write checks for companies like BRL Medicine. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View